Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Somatropin - Ferring Pharmaceuticals

Drug Profile

Somatropin - Ferring Pharmaceuticals

Alternative Names: Tev-Tropin; TevTropin; ZOMACTON; Zomacton

Latest Information Update: 06 Feb 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Savient Pharmaceuticals
  • Developer Elvetium; Ferring Pharmaceuticals; Teva Pharmaceuticals USA
  • Class Growth hormones; Hormonal replacements; Obesity therapies
  • Mechanism of Action Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Short stature; Somatotropin deficiency
  • Discontinued Cachexia

Most Recent Events

  • 06 Feb 2018 FDA approves somatropin for Somatotrophin deficiency (In adults) in USA (ADNM)
  • 31 Jan 2018 Registered for Somatotropin deficiency (In adults) in USA (SC; 5mg, 10mg)
  • 10 Oct 2017 Ferring Pharmaceuticals entered into an asset purchase agreement to acquire worldwide rights to somatotropin
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top